{
  "docId": "019de516-de84-709f-9864-0c2e708269aa",
  "docSlug": "d2a0e3b4a50bc196c7afb3f2c93e5906",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 38 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 38,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 72,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-de84-709f-9864-0c2e708269aa/33",
  "deckHref": "/decks/019de516-de84-709f-9864-0c2e708269aa",
  "deckJsonHref": "/decks/019de516-de84-709f-9864-0c2e708269aa.json",
  "deckAnchorHref": "/decks/019de516-de84-709f-9864-0c2e708269aa#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.74,
        "x": 0.16,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or non-GAAP ratio. See Slide 1 and this Appendix for further information on non-GAAP measures and ratios.\n2. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the\nreported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar\nproducts. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.\n3. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the\nmonthly average currency exchange rates during the comparable prior period.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b1231b1-8381-498e-a92d-9241ea08426b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.31,
        "w": 0.69,
        "x": 0.22,
        "y": 0.52
      },
      "kind": "table",
      "text": "Calculation of Constant Currency Revenue for the Nine Months Ended September 30, 2023, September 30, 2022, Reported Revenue, Constant Currency Revenue. Bausch + Lomb: Vision Care, Surgical, Pharmaceuticals, Total Bausch + Lomb.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "227c3efe-5b35-4eb8-9a90-23752eca8cff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.31,
        "w": 0.69,
        "x": 0.22,
        "y": 0.19
      },
      "kind": "table",
      "text": "Calculation of Constant Currency Revenue for the Three Months Ended September 30, 2023, September 30, 2022, Reported Revenue, Constant Currency Revenue. Bausch + Lomb: Vision Care, Surgical, Pharmaceuticals, Total Bausch + Lomb.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41a0a5fc-a3fa-476a-8837-44b1016abb4d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.906,
        "x": 0.049,
        "y": 0.04
      },
      "kind": "title",
      "text": "Reconciliation of Reported Revenue to Constant Currency Revenue¹ and Constant Currency Revenue Growth¹ ($M)",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3ef42dd-1a5b-423b-9d56-2939c249d44e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}